8. REFERENCES
LaPar DJ, Crosby IK, Rich JB, et al. A contemporary cost
analysis of postoperative morbidity after coronary artery by- pass
grafting with and without concomitant aortic valve replacement to
improve patient quality and cost-effective care . Ann Thorac Surg
2013;96:1621-7;
Maisel WH, Rawn JD, Stevenson WG. Atrial fibrillation after
cardiac surgery. Ann Intern Med. 2001;135(12):1061-1073.
doi:10.7326/0003-4819-135-12-200112180-00010;
Mathew JP, Fontes ML, Tudor IC, et al. A multicenter risk index
for atrial fibrillation after cardiac surgery. JAMA.
2004;291(14):1720-1729. doi:10.1001/jama.291.14.1720;
Villareal RP, Hariharan R, Liu BC, et al. Postoperative atrial
fibrillation and mortality after coronary artery bypass surgery. J Am
Coll Cardiol. 2004;43(5):742-748. doi:10.1016/j.jacc.2003.11.023;
Mariscalco G, Klersy C, Zanobini M, et al. Atrial fibrillation
after isolated coronary surgery affects late survival. Circulation.
2008;118(16):1612-1618. doi:10.1161/CIRCULATIONAHA.108.777789;
Creswell LL, Schuessler RB, Rosenbloom M, Cox JL. Hazards of
postoperative atrial arrhythmias. Ann Thorac Surg. 1993;56(3):539-549.
doi:10.1016/0003-4975(93)90894-n;
Asher CR, Miller DP, Grimm RA, Cosgrove DM 3rd, Chung MK.Analysis of risk factors for development of atrial fibrillation
early after cardiac valvular surgery. Am J Cardiol. 1998;82(7):892-895.
doi:10.1016/s0002-9149(98)00498-6;
Bramer S, van Straten AH, Soliman Hamad MA, Berreklouw E, Martens EJ,
Maessen JG. The impact of new-onset postoperative atrial
fibrillation on mortality after coronary artery bypass grafting. Ann
Thorac Surg. 2010;90(2):443-449. doi:10.1016/j.athoracsur.2010.03.083;
Saxena A, Dinh DT, Smith JA, Shardey GC, Reid CM, Newcomb AE.Usefulness of postoperative atrial fibrillation as an
independent predictor for worse early and late outcomes after isolated
coronary artery bypass grafting (multicenter Australian study of 19,497
patients). Am J Cardiol. 2012;109(2):219-225.
doi:10.1016/j.amjcard.2011.08.033;
Kosmidou I, Chen S, Kappetein AP, et al. New-Onset Atrial
Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial.J Am Coll Cardiol. 2018;71(7):739-748. doi:10.1016/j.jacc.2017.12.012;
Aranki SF, Shaw DP, Adams DH, et al. Predictors of atrial
fibrillation after coronary artery surgery. Current trends and impact on
hospital resources. Circulation. 1996;94(3):390-397.
doi:10.1161/01.cir.94.3.390;
Crystal E, Garfinkle MS, Connolly SS, Ginger TT, Sleik K, Yusuf SS.Interventions for preventing post-operative atrial fibrillation
in patients undergoing heart surgery. Cochrane Database Syst Rev.
2004;(4):CD003611. Published 2004 Oct 18.
doi:10.1002/14651858.CD003611.pub2;
Maesen B, Nijs J, Maessen J, Allessie M, Schotten U.Post-operative atrial fibrillation: a maze of mechanisms.Europace 2012;14:159-74;
Pinho-Gomes AC, Reilly S, Brandes RP, Casadei B. Targeting
inflammation and oxidative stress in atrial fibrillation: role of
3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibition with
statins. Antioxid Redox Signal 2014;20:1268-85;
Antoniades C, Demosthenous M, Reilly S, et al. Myocardial redox
state pre- dicts in-hospital clinical outcome after cardiac surgery
effects of short-term pre- operative statin treatment. J Am Coll
Cardiol 2012;59:60-70;
Antoniades C, Bakogiannis C, Leeson P, et al. Rapid, direct
effects of statin treatment on arterial redox state and nitric oxide
bioavailability in human atherosclerosis via
tetrahydrobiopterin-mediated endothelial nitric oxide synthase
coupling. Circulation 2011;124:335-45;
Kostapanos MS, Liberopoulos EN, Goudevenos JA, et al. Do statins
have an anti arrhythmic activity? Cardiovasc Res 2007; 75:10 – 20;
Fauchier L, Clementy N, Babuty D. Statin therapy and atrial
fibrillation: systematic review and updated meta-analysis of published
randomized controlled trials. Curr Opin Cardiol. 2013;28(1):7-18.
doi:10.1097/HCO.0b013e32835b0956;
Kuhn EW, Liakopoulos OJ, Stange S, et al. Preoperative statin
therapy in cardiac surgery: a meta-analysis of 90,000 patients. Eur J
Cardiothorac Surg 2014;45:17-26;
Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group.Preferred reporting items for systematic reviews and
meta-analyses: the PRISMA statement. PLoS Med .
2009;6(7):e1000097. doi:10.1371/journal.pmed.1000097;
Landis JR, Koch GG. The measurement of observer agreement for
categorical data. Biometrics . 1977;33(1):159-174;
Higgins J, Altman D, Sterne. Chapter 8: Assessing risk of bias
in included studies. In: Higgins J, Green S, eds. Cochrane Handbook for
Systematic Reviews of Interventions 5.1.0 ed. The Cochrane
Collaboration. https://handbook-5-1.cochrane.org/ 2011;
Higgins JP, Thompson SG. Quantifying heterogeneity in a
meta-analysis. Stat Med . 2002;21(11):1539-1558.
doi:10.1002/sim.1186;
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring
inconsistency in meta-analyses. BMJ . 2003;327(7414):557-560.
doi:10.1136/bmj.327.7414.557;
Allah EA, Kamel EZ, Osman HM, et al. Could Short-Term
Perioperative High-Dose Atorvastatin Offer Antiarrhythmic and
Cardio-Protective Effects in Rheumatic Valve Replacement Surgery?. J
Cardiothorac Vasc Anesth. 2019;33(12):3340-3347.
doi:10.1053/j.jvca.2019.05.013;
Baran Ç, Durdu S, Dalva K, et al. Effects of preoperative short
term use of atorvastatin on endothelial progenitor cells after coronary
surgery: a randomized, controlled trial. Stem Cell Rev Rep.
2012;8(3):963-971. doi:10.1007/s12015-011-9321-z;
Billings FT 4th, Hendricks PA, Schildcrout JS, et al. High-Dose
Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac
Surgery: A Randomized Clinical Trial. JAMA. 2016;315(9):877-888.
doi:10.1001/jama.2016.0548
Dehghani MR, Kasianzadeh M, Rezaei Y, Sepehrvand N. Atorvastatin
Reduces the Incidence of Postoperative Atrial Fibrillation in
Statin-Naive Patients Undergoing Isolated Heart Valve Surgery: A
Double-Blind, Placebo-Controlled Randomized Trial. J Cardiovasc
Pharmacol Ther. 2015;20(5):465-472. doi:10.1177/1074248414564869;
Ji Q, Mei Y, Wang X, et al. Effect of preoperative atorvastatin
therapy on atrial fibrillation following off-pump coronary artery bypass
grafting . Circ J. 2009;73(12):2244-2249. doi:10.1253/circj.cj-09-0352:
Mannacio VA, Iorio D, De Amicis V, Di Lello F, Musumeci F.Effect of rosuvastatin pretreatment on myocardial damage after
coronary surgery: a randomized trial. J Thorac Cardiovasc Surg.
2008;136(6):1541-1548. doi:10.1016/j.jtcvs.2008.06.038
Osmanovic E, Ostojic M, Avdic S, et al. Pharmacological
Prophylaxis of Atrial Fibrillation After Surgical Myocardial
Revascularization. Med Arch. 2019;73(1):19-22.
doi:10.5455/medarh.2019.73.19-22;
Park JH, Shim JK, Song JW, Soh S, Kwak YL. Effect of
atorvastatin on the incidence of acute kidney injury following valvular
heart surgery: a randomized, placebo-controlled trial. Intensive Care
Med. 2016;42(9):1398-1407. doi:10.1007/s00134-016-4358-8
Patti G, Chello M, Candura D, et al. Randomized trial of
atorvastatin for reduction of postoperative atrial fibrillation in
patients undergoing cardiac surgery: results of the ARMYDA-3
(Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac
surgery) study. Circulation. 2006;114(14):1455-1461.
doi:10.1161/CIRCULATIONAHA.106.621763;
Song YB, On YK, Kim JH, et al. The effects of atorvastatin on
the occurrence of postoperative atrial fibrillation after off-pump
coronary artery bypass grafting surgery. Am Heart J.
2008;156(2):373.e9-373.e3.73E16. doi:10.1016/j.ahj.2008.04.020;
Spadaccio C, Pollari F, Casacalenda A, et al. Atorvastatin
increases the number of endothelial progenitor cells after cardiac
surgery: a randomized control study. J Cardiovasc Pharmacol.
2010;55(1):30-38. doi:10.1097/FJC.0b013e3181c37d4d
Sun Y, Ji Q, Mei Y, et al. Role of preoperative atorvastatin
administration in protection against postoperative atrial fibrillation
following conventional coronary artery bypass grafting. Int Heart J.
2011;52(1):7-11. doi:10.1536/ihj.52.7;
Vukovic PM, Maravic-Stojkovic VR, Peric MS, et al. Steroids and
statins: an old and a new anti-inflammatory strategy compared.Perfusion. 2011;26(1):31-37. doi:10.1177/0267659110385607;
Zheng Z, Jayaram R, Jiang L, et al. Perioperative Rosuvastatin
in Cardiac Surgery. N Engl J Med. 2016;374(18):1744-1753.
doi:10.1056/NEJMoa1507750;
Soucier RJ, Mirza S, Abordo MG, et al. Predictors of conversion
of atrial fibrillation after cardiac operation in the absence of class I
or III antiarrhythmic medications. Ann Thorac Surg. 2001;72(3):694-698.
doi:10.1016/s0003-4975(01)02817-x;
Lee JK, Klein GJ, Krahn AD, et al. Rate-control versus
conversion strategy in postoperative atrial fibrillation: a prospective,
randomized pilot study . Am Heart J. 2000;140(6):871-877.
doi:10.1067/mhj.2000.111104;
Liakopoulos OJ, Kuhn EW, Hellmich M, et al. Statin Recapture
Therapy before Coronary Artery Bypass Grafting Trial: Rationale and
study design of a multicenter, randomized, double-blinded controlled
clinical trial. Am Heart J. 2015;170(1):46-54.e542.
doi:10.1016/j.ahj.2015.04.015;
Kuhn EW, Slottosch I, Wahlers T, Liakopoulos OJ. Preoperative
statin therapy for patients undergoing cardiac surgery. Cochrane
Database Syst Rev 2015;8: CD008493.